Megumi Murakami
6PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|May 25, 2024
ABCG2 Mediates Resistance to the Dual EGFR and PI3K Inhibitor MTX-211 in Cancer Cells.Chung-Pu Wu, Cheng-Yu Hung, Megumi Murakami
|Nov 25, 2023
Imperatorin Restores Chemosensitivity of Multidrug-Resistant Cancer Cells by Antagonizing ABCG2-Mediated Drug Transport.Chung-Pu Wu, Megumi Murakami, Yen-Ching Li
|Sep 28, 2023
Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, Overcomes Multidrug Resistance through Inhibiting ABCB1 and ABCG2 in Cancer Cells.Chung-Pu Wu, Yen-Ching Li, Megumi Murakami
|Apr 13, 2023
ABCB1 and ABCG2 Overexpression Mediates Resistance to the Phosphatidylinositol 3-Kinase Inhibitor HS-173 in Cancer Cell Lines.Chung-Pu Wu, Cheng-Yu Hung, Ya-Ju Hsieh
|Feb 25, 2023
Design, Synthesis and Biological Evaluation of Quinazolinamine Derivatives as Breast Cancer Resistance Protein and P-Glycoprotein Inhibitors with Improved Metabolic Stability.Chao-Yun Cai, Qiu-Xu Teng, Megumi Murakami
|Nov 10, 2020
Reversing the direction of drug transport mediated by the human multidrug transporter P-glycoprotein.Andaleeb Sajid, Sabrina Lusvarghi, Megumi Murakami
Pageof 1
Frequent Collaborators
6 joint publications
Suresh V Ambudkar
4 joint publications
Chung-Pu Wu
4 joint publications
Yu-Shan Wu
2 joint publications
Jau-Song Yu
1 joint publications
Andaleeb Sajid
1 joint publications
Sabrina Lusvarghi
1 joint publications
Michael M Gottesman
1 joint publications
Zhe-Sheng Chen
1 joint publications
Cheng-Yu Hung
